Quezada Lab

Immune Regulation and Tumour Immunotherapy Group led by @squezadd, based at the Cancer Institute of University College of London, UCL.

[Quezada Lab @QuezadaLab]

Come join our team! https://t.co/rUvOR8T7LV

[Quezada Lab @QuezadaLab]

https://t.co/U6zQA7uWHb. Come joint our lab Quezada Lab UCL Cancer Institute Cancer Research UK (CRUK) Cancer Research UK (CRUK) City of London Centre Great PhD opportunity to develop advanced immunotherapies against cancer

[Quezada Lab @QuezadaLab]

Congrats to Aurélien Marabelle’s team — intratumoural anti-CTLA-4 links Treg reduction with FcγR⁺ myeloid context, underscoring the FcγR landscape as a key determinant of CPI activity and translation. https://t.co/WdThERJRzy

[Cancer Grand Challenges @CancerGrand]

Congratulations to @CharlesSwanton, Mariam Jamal-Hanjani and colleagues on their fascinating analysis of the evolution of lung cancer metastasis published in @Nature!
https://t.co/96aszH5GBW

[Miriam Merad, MD, PhD @MiriamMerad]

Thrilled to see a new paper led by the outstanding @Brown_lab1, now out in Nature Biotechnology.
We provide mechanistic insights into how mRNA vaccines work. challenging key assumptions and offering new ways to control vaccine activity. (1/3)
Read here: https://t.co/zNZAGHJ9kd

[Parker Institute @parkerici]

Congrats to PICI researcher Dr. Catherine Wu of @DanaFarber on being part of the @CancerGrand ILLUMINE team, awarded $25M to explore the cancer dark proteome, research that could uncover entirely new targets for cancer treatment. https://t.co/B2DoF0KQTf

[Walczak Lab @Walczak_Lab]

Excited to share our new work uncovering a previously unknown mechanism identifying ANKIB1 as the E3 ligase that writes a critical new letter of the ubiquitin code central for immune signalling: K11-linked ubiquitin https://t.co/B9BQpsaVeV

[Quezada Lab @QuezadaLab]

Come join our team!! https://t.co/aA0YanfGEk

[Kane Foster @KaneFos]

Huge thanks to the team at UCLH and the UCL Cancer Institute @ucl @uclh @uclcancer, particularly Elise Reese @ekvrees and Louise Ainley, and my mentors Benny Chain @BennyChain, Sergio Quezada @QuezadaLab and Kwee Yong.

[Miriam Merad, MD, PhD @MiriamMerad]

Immunology takes center stage again at the #NobelPrize! Congratulations to Mary Brunkow, Fred Ramsdell & Shimon Sakaguchi for uncovering how regulatory T cells maintain immune tolerance—a discovery that transformed our understanding of autoimmunity and cancer immunotherapy

[Quezada Lab @QuezadaLab]

Are you looking for a Clinical Research Training Fellowship? Do you want join our team working in cancer immunology and immunotherapy? Check this great opportunity from @CRUKCOLcentre
https://t.co/AHeV3QjwSY
 and contact our team to discuss our proposed project

[Richard Jenner @RegGenomics]

Pleased to share our preprint describing a central role for post-transcriptional processes in the response to cancer immunotherapy. Huge amount of work led by Maria Vila de Mucha and @julia_hlond in collaboration with @QuezadaLab and @MartT_babraham 1/8

https://t.co/o5zDjBEC6X

[Claire Roddie @drclaireroddie]

🧬 Join us Friday 19th Sept for CART Autoimmunity Symposium in Central London 🧬 Guest speakers from Erlangen & Hamburg on latest developments in Lupus, Multiple Sclerosis, & MG. Register in link below & see you there! ⁦⁦@uclh⁩ ⁦@uclcancer⁩ https://t.co/rww9s0PnS6

[Quezada Lab @QuezadaLab]

@Chrystal_Paulos What is the true activity of each of the many subsets of myeloid cells in tumours and can they be coordinated towards a single (tumour-targeting) activity?

[ACIR @ACIR_org]

Depletion of Tregs with a non-IL-2-blocking anti-CD25  enhanced antitumor responses in brain tumors and synergized with anti-PD-1 or a tumor antigen-targeted antibody https://t.co/FR8gfFbGn0  @uclcancer  @QuezadaLab #Immunotherapy

[soria @jsoriamd]

CHIP is a common, age-related condition where mutated blood stem cells expand without causing blood disorders. CHIP raises the risk of hematological malignancies, chronic inflammatory diseases (like heart & lung disease), & lung cancer. This manuscript shows that CHIP somatic clones in blood—especially TET2 mutant ones—migrate into tumors, reshape immunity, drive progression, and promote recurrence. The ability of a somatic clonal expansion in the hematopoietic compartment, to regulate malignant progression in another tissue represents a new perspective in cancer biology. #CHIP #LCMS #cancer #biology #AACR25 https://t.co/EvOASp0Vi0

[Quezada Lab @QuezadaLab]

Regulatory T cell depletion promotes myeloid cell activation and glioblastoma response to anti-PD1 and tumor-targeting antibodies: https://t.co/EB5a9vTrLO
Amazing collaboration led by @CR_UK funded @QuezadaLab @galvez_cancino @uclcancer and colleagues!

[Quezada Lab @QuezadaLab]

@CancerGrand @CharlesSwanton Congratulations!!!!

[E. John Wherry @EJohnWherry]

This is exactly right. Gutting the NIH will lead to a rapid labor shortage and all these jobs going overseas

[Charles Swanton @CharlesSwanton]

Many congratulations ⁦@FAndreMD⁩ ⁦@cncurtis⁩ on the Susan G Komen awards - a great recognition for all your discoveries
So well deserved